Epitel Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 48

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $26M

  • Investors
  • 22

Epitel General Information

Description

Developer of a brain health monitoring device designed to detect abnormal brain activities accurately. The company's device leverages a cloud-based wearable sensor system and innovative artificial intelligence (AI) technologies to provide accessible, affordable and reliable electrographic seizure detection, enabling physicians, caregivers and patients suffering from neurological disorders to access brain health insights to improve the quality of life and care.

Contact Information

Website
www.epitel.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 465 South 400 East
  • Suite 250
  • Salt Lake City, UT 84111
  • United States
+1 (801)
Primary Industry
Monitoring Equipment
Vertical(s)
Digital Health, SaaS, Wearables & Quantified Self
Corporate Office
  • 465 South 400 East
  • Suite 250
  • Salt Lake City, UT 84111
  • United States
+1 (801)

Epitel Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epitel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series B) 28-Jul-2026 $26M Completed Generating Revenue
12. Accelerator/Incubator 01-Dec-2023 Completed Generating Revenue
11. Later Stage VC (Series A1) 31-Jan-2022 Completed Generating Revenue
10. Grant 15-May-2021 Completed Product Development
9. Accelerator/Incubator 01-Jun-2020 Completed Product Development
8. Grant Completed Product Development
7. Later Stage VC (Series A) 29-Oct-2019 Completed Product Development
6. Grant 23-Sep-2019 Completed Product Development
5. Grant 01-Sep-2017 $2.1M Completed Product Development
4. Grant 30-Sep-2016 $1.05M Completed Startup
To view Epitel’s complete valuation and funding history, request access »

Epitel Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B-2
Series B-1
Series A-2 490,732 $0.000100 $0.99 $0.99 1x $0.99 2.14%
Series A-1 6,841,805 $0.000100 $3 $3 1x $3 29.8%
To view Epitel’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Epitel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a brain health monitoring device designed to detect abnormal brain activities accurately. The company's dev
Monitoring Equipment
Salt Lake City, UT
48 As of 2025

Sunnyvale, CA
 

Carlsbad, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Epitel Competitors (5)

One of Epitel’s 5 competitors is Ceribell, a Formerly VC-backed company based in Sunnyvale, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ceribell Formerly VC-backed Sunnyvale, CA
Advanced Brain Monitoring Angel-Backed Carlsbad, CA
Empatica Venture Capital-Backed Cambridge, MA
NeuroSky Formerly VC-backed San Jose, CA
EMOTIV Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 5 competitors. Get the full list »

Epitel Patents

  • 66

    Total Documents Applications and Grants

  • Total Patents Families

  • 37

    Granted

  • 20

    Pending

  • Expiring in next 12 mo

Epitel Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025207347-A1 Electroencephalogram sensor with multiple active electrodes Pending 27-Mar-2024
AU-2024282933-A1 Adaptive systems and methods for seizure detection Pending 01-Jun-2023
EP-4719176-A1 Adaptive systems and methods for seizure detection Pending 01-Jun-2023
JP-2026522238-A Adaptive systems and methods for seizure detection Pending 01-Jun-2023
US-20240398322-A1 Adaptive systems and methods for seizure detection Active 01-Jun-2023 A61B5/0006
To view Epitel’s complete patent history, request access »

Epitel Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Epitel Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dendrion Ventures Venture Capital Minority
MedTech Angels Angel Group Minority
Southwest National Pediatric Device Innovation Consortium Accelerator/Incubator
Angel Physicians Fund Angel Group Minority
Catalyst Health Ventures Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

Ready to get started?

Request a free trial

Epitel FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process